Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16564606 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.
Conditions: Tuberculosis;   Healthy
Intervention: Biological: Biological MTBVAC and biological BCG (commercial)

Indicates status has not been verified in more than two years